Literature DB >> 15116801

Approach to managing diabetic foot ulcers.

John A A Nesbitt1.   

Abstract

INTRODUCTION: Of an estimated 1.7 to 2 million Canadians with diabetes, approximately 10% will present each year to their family doctors with plantar ulcers. Nearly 3500 will require major lower extremity amputations. SOURCES OF INFORMATION: Most of the recommendations outlined in this paper are based on level I evidence from excellent bench research and epidemiologic studies. MAIN MESSAGE: Both insulin-dependent and non-insulin-dependent diabetics develop foot infections. These patients are on average 60 years old and have had diabetes for more than 10 years. Physicians who insist on excellent blood sugar control, provide ongoing patient education on diabetic foot care, prescribe appropriate shoes, and practise an aggressive multidisciplinary approach to wound care can reduce the rate of lower extremity amputations by more than 50%.
CONCLUSION: Foot problems remain one of the main challenges associated with diabetes, but family physicians can manage them successfully.

Entities:  

Mesh:

Year:  2004        PMID: 15116801      PMCID: PMC2214577     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  4 in total

1.  Amputation of the lower extremity in diabetes mellitus; a follow-up study of 294 cases.

Authors:  S SILBERT
Journal:  Diabetes       Date:  1952 Jul-Aug       Impact factor: 9.461

2.  The later life of the diabetic amputee. Another look at fate of the second leg.

Authors:  F W Whitehouse; C Jurgensen; M A Block
Journal:  Diabetes       Date:  1968-08       Impact factor: 9.461

3.  Chronology and determinants of tissue repair in diabetic lower-extremity ulcers.

Authors:  R E Pecoraro; J H Ahroni; E J Boyko; V L Stensel
Journal:  Diabetes       Date:  1991-10       Impact factor: 9.461

4.  The epidemiology of lower extremity amputations in diabetic individuals.

Authors:  R S Most; P Sinnock
Journal:  Diabetes Care       Date:  1983 Jan-Feb       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.